quotient sciences limited
quotient sciences limited Company Information
Company Number
05221615
Next Accounts
Sep 2025
Shareholders
quad uk bidco limited
Group Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
trent house, mere way, ruddington fields busi, nottingham, NG11 6JS
Website
http://arcinova.comquotient sciences limited Estimated Valuation
Pomanda estimates the enterprise value of QUOTIENT SCIENCES LIMITED at £208.8m based on a Turnover of £74.3m and 2.81x industry multiple (adjusted for size and gross margin).
quotient sciences limited Estimated Valuation
Pomanda estimates the enterprise value of QUOTIENT SCIENCES LIMITED at £165.2m based on an EBITDA of £14.9m and a 11.08x industry multiple (adjusted for size and gross margin).
quotient sciences limited Estimated Valuation
Pomanda estimates the enterprise value of QUOTIENT SCIENCES LIMITED at £261.1m based on Net Assets of £145.8m and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Quotient Sciences Limited Overview
Quotient Sciences Limited is a live company located in nottingham, NG11 6JS with a Companies House number of 05221615. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in September 2004, it's largest shareholder is quad uk bidco limited with a 100% stake. Quotient Sciences Limited is a mature, large sized company, Pomanda has estimated its turnover at £74.3m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Quotient Sciences Limited Health Check
Pomanda's financial health check has awarded Quotient Sciences Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 2 areas for improvement. Company Health Check FAQs
7 Strong
3 Regular
2 Weak
Size
annual sales of £74.3m, make it larger than the average company (£4.4m)
£74.3m - Quotient Sciences Limited
£4.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 18%, show it is growing at a faster rate (13.5%)
18% - Quotient Sciences Limited
13.5% - Industry AVG
Production
with a gross margin of 50.5%, this company has a comparable cost of product (54.2%)
50.5% - Quotient Sciences Limited
54.2% - Industry AVG
Profitability
an operating margin of 14.2% make it more profitable than the average company (-4.7%)
14.2% - Quotient Sciences Limited
-4.7% - Industry AVG
Employees
with 653 employees, this is above the industry average (54)
653 - Quotient Sciences Limited
54 - Industry AVG
Pay Structure
on an average salary of £46.1k, the company has a lower pay structure (£83.1k)
£46.1k - Quotient Sciences Limited
£83.1k - Industry AVG
Efficiency
resulting in sales per employee of £113.7k, this is equally as efficient (£131.4k)
£113.7k - Quotient Sciences Limited
£131.4k - Industry AVG
Debtor Days
it gets paid by customers after 58 days, this is near the average (56 days)
58 days - Quotient Sciences Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 32 days, this is quicker than average (61 days)
32 days - Quotient Sciences Limited
61 days - Industry AVG
Stock Days
it holds stock equivalent to 1 days, this is less than average (48 days)
1 days - Quotient Sciences Limited
48 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 13 weeks, this is less cash available to meet short term requirements (30 weeks)
13 weeks - Quotient Sciences Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 37.2%, this is a lower level of debt than the average (52.7%)
37.2% - Quotient Sciences Limited
52.7% - Industry AVG
QUOTIENT SCIENCES LIMITED financials
Quotient Sciences Limited's latest turnover from December 2023 is £74.3 million and the company has net assets of £145.8 million. According to their latest financial statements, Quotient Sciences Limited has 653 employees and maintains cash reserves of £11.5 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 74,270,000 | 81,855,000 | 70,573,000 | 44,763,000 | 64,218,000 | 56,622,000 | 43,379,000 | 41,126,000 | 38,509,000 | 31,171,000 | 8,084,000 | ||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | 36,734,000 | 39,466,000 | 34,114,000 | 22,143,000 | 32,480,000 | 28,157,000 | 21,081,000 | 22,259,000 | 17,397,000 | 16,369,000 | 4,873,000 | ||||
| Gross Profit | 37,536,000 | 42,389,000 | 36,459,000 | 22,620,000 | 31,738,000 | 28,465,000 | 22,298,000 | 18,867,000 | 21,112,000 | 14,802,000 | 3,211,000 | ||||
| Admin Expenses | 26,991,000 | 22,139,000 | 21,451,000 | 18,933,000 | 29,133,000 | 13,806,000 | 12,404,000 | 8,599,000 | 9,791,000 | 8,639,000 | 11,802,000 | ||||
| Operating Profit | 10,545,000 | 20,250,000 | 15,008,000 | 3,687,000 | 2,605,000 | 14,659,000 | 9,894,000 | 10,268,000 | 11,321,000 | 6,163,000 | -8,591,000 | ||||
| Interest Payable | 4,432,000 | 3,496,000 | 2,617,000 | 2,924,000 | 902,000 | 297,000 | 652,000 | 143,000 | 2,253,000 | 3,002,000 | 364,000 | ||||
| Interest Receivable | 6,501,000 | 4,335,000 | 2,807,000 | 1,732,000 | 1,843,000 | 607,000 | 246,000 | 957,000 | 974,000 | 324,000 | 6,000 | 5,000 | 4,000 | 4,000 | 4,000 |
| Pre-Tax Profit | 12,614,000 | 21,089,000 | 15,198,000 | 2,893,000 | 3,546,000 | 14,969,000 | 9,488,000 | 11,082,000 | 42,042,000 | 3,485,000 | -8,949,000 | 5,000 | 4,000 | 4,000 | 4,000 |
| Tax | -2,070,000 | -5,374,000 | -3,146,000 | -786,000 | -2,555,000 | -3,215,000 | -2,318,000 | -2,476,000 | -2,219,000 | -594,000 | 981,000 | ||||
| Profit After Tax | 10,544,000 | 15,715,000 | 12,052,000 | 2,107,000 | 991,000 | 11,754,000 | 7,170,000 | 8,606,000 | 39,823,000 | 2,891,000 | -7,968,000 | 5,000 | 4,000 | 4,000 | 4,000 |
| Dividends Paid | 24,514,000 | 5,120,000 | |||||||||||||
| Retained Profit | 10,544,000 | 15,715,000 | 12,052,000 | 2,107,000 | 991,000 | 11,754,000 | 7,170,000 | -15,908,000 | 34,703,000 | 2,891,000 | -7,968,000 | 5,000 | 4,000 | 4,000 | 4,000 |
| Employee Costs | 30,115,000 | 29,834,000 | 24,442,000 | 16,855,000 | 22,650,000 | 17,528,000 | 14,388,000 | 13,677,000 | 10,664,000 | 8,046,000 | 2,342,000 | ||||
| Number Of Employees | 653 | 651 | 555 | 532 | 518 | 413 | 365 | 341 | 278 | 223 | 197 | ||||
| EBITDA* | 14,912,000 | 24,416,000 | 18,853,000 | 9,152,000 | 6,572,000 | 17,505,000 | 12,571,000 | 12,732,000 | 13,452,000 | 8,052,000 | -8,022,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 21,362,000 | 21,092,000 | 17,659,000 | 8,997,000 | 9,310,000 | 7,011,000 | 6,215,000 | 5,450,000 | 5,025,000 | 2,771,000 | 2,432,000 | ||||
| Intangible Assets | 19,931,000 | 18,777,000 | 18,699,000 | 18,172,000 | 21,821,000 | 20,331,000 | 21,308,000 | 22,526,000 | 23,915,000 | 25,321,000 | 26,661,000 | ||||
| Investments & Other | 75,210,000 | 75,210,000 | 75,210,000 | 484,000 | 2,602,000 | 19,055,000 | 18,948,000 | 1,388,000 | 1,638,000 | 9,328,000 | 9,328,000 | 9,328,000 | 9,328,000 | ||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 116,503,000 | 115,079,000 | 111,568,000 | 27,653,000 | 33,733,000 | 46,397,000 | 46,471,000 | 29,364,000 | 30,578,000 | 28,092,000 | 29,093,000 | 9,328,000 | 9,328,000 | 9,328,000 | 9,328,000 |
| Stock & work in progress | 196,000 | 180,000 | 228,000 | 162,000 | 100,000 | 272,000 | 130,000 | 97,000 | 53,000 | 41,000 | 77,000 | ||||
| Trade Debtors | 11,912,000 | 10,419,000 | 20,404,000 | 9,846,000 | 8,517,000 | 7,249,000 | 7,212,000 | 5,896,000 | 4,384,000 | 4,434,000 | 3,153,000 | ||||
| Group Debtors | 83,187,000 | 59,890,000 | 34,885,000 | 24,080,000 | 21,106,000 | 11,753,000 | 4,069,000 | 943,000 | 14,071,000 | 7,930,000 | 491,000 | 64,000 | 59,000 | 55,000 | 51,000 |
| Misc Debtors | 8,954,000 | 10,324,000 | 3,918,000 | 13,482,000 | 11,762,000 | 9,345,000 | 10,010,000 | 7,115,000 | 5,304,000 | 4,602,000 | 3,921,000 | ||||
| Cash | 11,518,000 | 2,794,000 | 8,360,000 | 5,825,000 | 18,122,000 | 8,765,000 | 5,245,000 | 4,347,000 | 2,078,000 | 3,232,000 | 1,849,000 | ||||
| misc current assets | |||||||||||||||
| total current assets | 115,767,000 | 83,607,000 | 67,795,000 | 53,395,000 | 59,607,000 | 37,384,000 | 26,666,000 | 18,398,000 | 25,890,000 | 20,239,000 | 9,491,000 | 64,000 | 59,000 | 55,000 | 51,000 |
| total assets | 232,270,000 | 198,686,000 | 179,363,000 | 81,048,000 | 93,340,000 | 83,781,000 | 73,137,000 | 47,762,000 | 56,468,000 | 48,331,000 | 38,584,000 | 9,392,000 | 9,387,000 | 9,383,000 | 9,379,000 |
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | 3,316,000 | 3,205,000 | 22,236,000 | 3,588,000 | 4,206,000 | 2,893,000 | 2,984,000 | 2,601,000 | 1,985,000 | 2,479,000 | 1,538,000 | ||||
| Group/Directors Accounts | 20,139,000 | 19,725,000 | 15,471,000 | 9,794,000 | 16,672,000 | 4,511,000 | 6,403,000 | 8,864,000 | 3,524,000 | 32,818,000 | |||||
| other short term finances | |||||||||||||||
| hp & lease commitments | 1,001,000 | 1,096,000 | 1,089,000 | 67,000 | 153,000 | 144,000 | |||||||||
| other current liabilities | 20,728,000 | 22,093,000 | 6,710,000 | 21,624,000 | 19,743,000 | 19,370,000 | 18,633,000 | 13,120,000 | 11,721,000 | 8,355,000 | 5,780,000 | ||||
| total current liabilities | 45,184,000 | 46,119,000 | 45,506,000 | 35,006,000 | 40,621,000 | 26,774,000 | 28,020,000 | 24,652,000 | 17,383,000 | 43,796,000 | 7,318,000 | ||||
| loans | 28,268,000 | 5,728,000 | 5,646,000 | 6,025,000 | 15,000,000 | 29,842,000 | |||||||||
| hp & lease commitments | 11,069,000 | 9,039,000 | 7,084,000 | 67,000 | 220,000 | ||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | 1,941,000 | 2,536,000 | 1,578,000 | 1,236,000 | 1,045,000 | 949,000 | 813,000 | ||||||||
| total long term liabilities | 41,278,000 | 17,303,000 | 14,308,000 | 7,261,000 | 16,045,000 | 949,000 | 813,000 | 67,000 | 220,000 | 29,842,000 | |||||
| total liabilities | 86,462,000 | 63,422,000 | 59,814,000 | 42,267,000 | 56,666,000 | 27,723,000 | 28,833,000 | 24,652,000 | 17,450,000 | 44,016,000 | 37,160,000 | ||||
| net assets | 145,808,000 | 135,264,000 | 119,549,000 | 38,781,000 | 36,674,000 | 56,058,000 | 44,304,000 | 23,110,000 | 39,018,000 | 4,315,000 | 1,424,000 | 9,392,000 | 9,387,000 | 9,383,000 | 9,379,000 |
| total shareholders funds | 145,808,000 | 135,264,000 | 119,549,000 | 38,781,000 | 36,674,000 | 56,058,000 | 44,304,000 | 23,110,000 | 39,018,000 | 4,315,000 | 1,424,000 | 9,392,000 | 9,387,000 | 9,383,000 | 9,379,000 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 10,545,000 | 20,250,000 | 15,008,000 | 3,687,000 | 2,605,000 | 14,659,000 | 9,894,000 | 10,268,000 | 11,321,000 | 6,163,000 | -8,591,000 | ||||
| Depreciation | 3,573,000 | 3,536,000 | 3,345,000 | 1,462,000 | 1,888,000 | 1,220,000 | 1,052,000 | 886,000 | 599,000 | 542,000 | 117,000 | ||||
| Amortisation | 794,000 | 630,000 | 500,000 | 4,003,000 | 2,079,000 | 1,626,000 | 1,625,000 | 1,578,000 | 1,532,000 | 1,347,000 | 452,000 | ||||
| Tax | -2,070,000 | -5,374,000 | -3,146,000 | -786,000 | -2,555,000 | -3,215,000 | -2,318,000 | -2,476,000 | -2,219,000 | -594,000 | 981,000 | ||||
| Stock | 16,000 | -48,000 | 66,000 | -110,000 | -172,000 | 142,000 | 33,000 | 44,000 | 12,000 | -36,000 | 77,000 | ||||
| Debtors | 23,420,000 | 21,426,000 | 11,799,000 | 19,061,000 | 13,038,000 | 7,056,000 | 7,337,000 | -9,805,000 | 6,793,000 | 9,401,000 | 7,501,000 | 5,000 | 4,000 | 4,000 | 51,000 |
| Creditors | 111,000 | -19,031,000 | 18,648,000 | 695,000 | 1,313,000 | -91,000 | 383,000 | 616,000 | -494,000 | 941,000 | 1,538,000 | ||||
| Accruals and Deferred Income | -1,365,000 | 15,383,000 | -14,914,000 | 2,254,000 | 373,000 | 737,000 | 5,513,000 | 1,399,000 | 3,366,000 | 2,575,000 | 5,780,000 | ||||
| Deferred Taxes & Provisions | -595,000 | 958,000 | 342,000 | 287,000 | 96,000 | 136,000 | 813,000 | ||||||||
| Cash flow from operations | -12,443,000 | -5,026,000 | 7,918,000 | -7,349,000 | -7,067,000 | 7,874,000 | 9,592,000 | 22,032,000 | 7,300,000 | 1,609,000 | -7,301,000 | -5,000 | -4,000 | -4,000 | -51,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 74,726,000 | -18,571,000 | -16,453,000 | 107,000 | 17,560,000 | -250,000 | 1,638,000 | -9,328,000 | 9,328,000 | ||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | 414,000 | 4,254,000 | 5,677,000 | 5,283,000 | 12,161,000 | -1,892,000 | -2,461,000 | 5,340,000 | -29,294,000 | 32,818,000 | |||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | 22,540,000 | 82,000 | -379,000 | 6,025,000 | 15,000,000 | -29,842,000 | 29,842,000 | ||||||||
| Hire Purchase and Lease Commitments | 1,935,000 | 1,962,000 | 8,173,000 | -67,000 | -153,000 | -144,000 | 364,000 | ||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | 2,069,000 | 839,000 | 190,000 | -1,192,000 | 941,000 | 310,000 | -406,000 | 814,000 | -1,279,000 | -2,678,000 | -358,000 | 5,000 | 4,000 | 4,000 | 4,000 |
| cash flow from financing | 26,958,000 | 7,137,000 | 82,377,000 | -9,268,000 | 7,727,000 | -1,582,000 | 11,090,000 | 6,001,000 | -30,717,000 | 662,000 | 29,484,000 | 5,000 | 4,000 | 4,000 | 9,379,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 8,724,000 | -5,566,000 | 2,535,000 | -2,940,000 | 9,357,000 | 3,520,000 | 898,000 | 2,269,000 | -1,154,000 | 1,383,000 | 1,849,000 | ||||
| overdraft | |||||||||||||||
| change in cash | 8,724,000 | -5,566,000 | 2,535,000 | -2,940,000 | 9,357,000 | 3,520,000 | 898,000 | 2,269,000 | -1,154,000 | 1,383,000 | 1,849,000 |
quotient sciences limited Credit Report and Business Information
Quotient Sciences Limited Competitor Analysis
Perform a competitor analysis for quotient sciences limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in NG11 area or any other competitors across 12 key performance metrics.
quotient sciences limited Ownership
QUOTIENT SCIENCES LIMITED group structure
Quotient Sciences Limited has 3 subsidiary companies.
Ultimate parent company
PERMIRA VI LP 1
#0106924
2 parents
QUOTIENT SCIENCES LIMITED
05221615
3 subsidiaries
quotient sciences limited directors
Quotient Sciences Limited currently has 2 directors. The longest serving directors include Mr Desmond Glass (May 2022) and Mr Thierry Nieuwenhove (Oct 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Desmond Glass | 55 years | May 2022 | - | Director | |
| Mr Thierry Nieuwenhove | England | 52 years | Oct 2023 | - | Director |
P&L
December 2023turnover
74.3m
-9%
operating profit
10.5m
-48%
gross margin
50.6%
-2.41%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
145.8m
+0.08%
total assets
232.3m
+0.17%
cash
11.5m
+3.12%
net assets
Total assets minus all liabilities
quotient sciences limited company details
company number
05221615
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
September 2004
age
21
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
quotient clinical limited (November 2017)
pharmaceutical profiles group limited (December 2013)
accountant
-
auditor
KPMG LLP
address
trent house, mere way, ruddington fields busi, nottingham, NG11 6JS
Bank
HSBC BANK PLC
Legal Advisor
LATHAM & WATKINS
quotient sciences limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 10 charges/mortgages relating to quotient sciences limited. Currently there are 1 open charges and 9 have been satisfied in the past.
quotient sciences limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for QUOTIENT SCIENCES LIMITED. This can take several minutes, an email will notify you when this has completed.
quotient sciences limited Companies House Filings - See Documents
| date | description | view/download |
|---|
